2019
Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function.
Shahin T,
Aschenbrenner D,
Cagdas D,
Bal SK,
Conde CD,
Garncarz W,
MedgyesiD,
Schwerd T,
Karaatmaca B,
Cetinkaya PG,
Esenboga S,
Twigg SRF,
Cant A,
WilkieAOM,
Tezcan I,
Uhlig HH,
Boztug K.
Haematologica. 2019 Mar;104(3):609-621. doi:10.3324/haematol.2018.194233. Epub 2018 Oct 11.
2019
CRISPR/Cas9 guided genome and epigenome engineering and its therapeutic applications in immune mediated diseases.
Singh DD,
Hawkins RD,
Lahesmaa R,
Tripathi SK.
Semin Cell Dev Biol. 2019 Jun 19. pii: S1084-9521(18)30111-3. doi:10.1016/j.semcdb.2019.05.007. [Epub ahead of print] Review.
2019
Roles of SETD2 in Leukemia-Transcription, DNA-Damage, and Beyond.
Skucha A,
Ebner J,
Grebien F.
Int J Mol Sci. 2019 Feb 27;20(5). pii: E1029. doi:10.3390/ijms20051029. Review.
2019
Spatiotemporal structure of cell fate decisions in murine neural crest.
Soldatov R,
Kaucka M,
Kastriti ME,
Petersen J,
Chontorotzea T,
Englmaier L,Akkuratova N,
Yang Y,
Häring M,
Dyachuk V,
Bock C,
Farlik M,
Piacentino ML,Boismoreau F,
Hilscher MM,
Yokota C,
Qian X,
Nilsson M,
Bronner ME,
Croci L,Hsiao WY,
Guertin DA,
Brunet JF,
Consalez GG,
Ernfors P,
Fried K,
Kharchenko PV,
Adameyko I.
Science. 2019 Jun 7;364(6444). pii: eaas9536. doi:10.1126/science.aas9536.
2019
Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses.
Spencer S,
Köstel Bal S,
Egner W,
Lango Allen H,
Raza SI,
Ma CA,
Gürel M,Zhang Y,
Sun G,
Sabroe RA,
Greene D,
Rae W,
Shahin T,
Kania K,
Ardy RC,
Thian M,
Staples E,
Pecchia-Bekkum A,
Worrall WPM,
Stephens J,
Brown M,
Tuna S,
York M,Shackley F,
Kerrin D,
Sargur R,
Condliffe A,
Tipu HN,
Kuehn HS,
Rosenzweig SD,Turro E,
Tavaré S,
Thrasher AJ,
Jodrell DI,
Smith KGC,
Boztug K,
Milner JD,Thaventhiran JED.
J Exp Med. 2019 Jun 24. pii:jem.20190344. doi: 10.1084/jem.20190344. [Epub ahead of print]
2019
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia (T-PLL).
Staber PB,
Herling M,
Bellido M,
Jacobsen ED,
Davids MS,
Kadia TM,
Shustov A,Tournilhac O,
Bachy E,
Zaja F,
Porkka K,
Hoermann G,
Simonitsch I,
Haferlach C,Kubicek S,
Mayerhoefer M,
Hopfinger G,
Jaeger U,
Dearden C.
Blood. 2019 Jul 10. pii: blood.2019000402. doi: 10.1182/blood.2019000402. [Epub ahead of print]
2019
Identification and characterization of cancer vulnerabilities via targeted protein degradation.
Mayor-Ruiz C,
Winter GE.
Drug Discov Today Technol. 2019Apr;31:81-90. doi: 10.1016/j.ddtec.2018.12.003. Epub 2019 Jan 2. Review.
2019
High activation of STAT5A drives peripheral T-cell lymphoma and leukemia.
Maurer B,
Nivarthi H,
Wingelhofer B,
Pham HTT,
Schlederer M,
Suske T,Grausenburger R,
Schiefer AI,
Prchal-Murphy M,
Chen D,
Winkler S,
Merkel O,Kornauth C,
Hofbauer M,
Hochgatterer B,
Hoermann G,
Hoelbl-Kovacic A,
ProchazkovaJ,
Lobello C,
Cumaraswamy AA,
Latzka J,
Kitzwögerer M,
Chott A,
Janikova A,Pospíšilova Š,
Loizou JI,
Kubicek S,
Valent P,
Kolbe T,
Grebien F,
Kenner L,Gunning PT,
Kralovics R,
Herling M,
Müller M,
Rülicke T,
Sexl V,
Moriggl R.
Haematologica. 2019 May 23. pii: haematol.2019.216986. doi:10.3324/haematol.2019.216986. [Epub ahead of print]
2019
RANK deletion in neuropeptide Y neurones attenuates oestrogen deficiency-related bone loss.
Lee NJ,
Clarke IM,
Zengin A,
Enriquez RF,
Nagy V,
Penninger JM,
Baldock PA,Herzog H.
J Neuroendocrinol. 2019 Feb;31(2):e12687. doi:10.1111/jne.12687. Epub 2019 Feb 1.
2019
BRCA2 deficiency instigates cGAS-mediated inflammatory signaling and confers sensitivity to tumor necrosis factor-alpha-mediated cytotoxicity.
Heijink AM,
Talens F,
Jae LT,
van Gijn SE,
Fehrmann RSN,
Brummelkamp TR,
van Vugt MATM.
NatCommun. 2019 Jan 9;10(1):100. doi: 10.1038/s41467-018-07927-y. PubMed PMID:30626869;
